Telehealth General Psychiatry Prescribing: What PMHNPs Can Do in Florida

If you’re a psychiatrist considering telehealth—or already practicing remotely—you’ve probably asked yourself: Can I legally prescribe medications through video visits? What about controlled substances like Adderall or Xanax?

The short answer: Yes, psychiatrists can prescribe most psychiatric medications via telehealth in 2026, including controlled substances. But the rules vary by state, and federal policy remains in flux.

Let’s cut through the noise and talk about what you can actually do, what the regulations say, and how this affects your practice.

The Federal Landscape: DEA Flexibilities Are Still in Effect (For Now)

Here’s the big one: under normal circumstances, federal law (the Ryan Haight Act) requires an in-person exam before prescribing Schedule II–V controlled substances. That means technically, you couldn’t start someone on Adderall or Klonopin via video alone.

But during COVID-19, the DEA waived that requirement. As of February 2026, that waiver is still active—extended through December 31, 2025, and likely to continue into 2026 given ongoing political support for telehealth access (texasnp.org) (natlawreview.com).

What this means for you:
You can conduct an initial psychiatric evaluation via secure video and prescribe stimulants, benzodiazepines, buprenorphine, or other controlled meds—no in-person visit required—as long as the standard of care is met.

The catch:
The DEA has proposed permanent rules that could reinstate some in-person requirements (or create alternative pathways like a special telemedicine registration). Those rules haven’t been finalized yet, so we’re in a holding pattern. Keep an eye on DEA announcements through late 2024 and 2025—your ability to prescribe Schedule II medications remotely could change.

For now, though, telepsychiatry providers are operating under the most permissive federal environment we’ve had.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Rules: Where It Gets Complicated

Federal law sets the floor, but states can add their own restrictions. Some states explicitly allow teleprescribing of controlled substances for mental health treatment. Others don’t.

Let’s break down the key states:

Florida: Explicitly Permits Teleprescribing for Psychiatric Treatment

Florida is one of the most telehealth-friendly states for psychiatry. State law allows controlled substances to be prescribed via telehealth specifically for the treatment of psychiatric disorders (www.flsenate.gov).

Translation: A Florida-licensed psychiatrist can start a new patient on ADHD stimulants or prescribe benzodiazepines for anxiety entirely through video visits. The only prohibition is for chronic pain management via telehealth—you’d need an in-person exam for long-term opioid therapy.

This carve-out makes Florida one of the best states for building a telepsychiatry practice focused on medication management.

Texas: Telemedicine Allowed, But Chronic Pain Is Off-Limits

Texas updated its telemedicine laws in 2017, and psychiatrists can generally prescribe via video if the standard of care is met (www.cchpca.org).

However, Texas prohibits prescribing opioids for chronic pain via telemedicine—you’d need an in-person visit for that. For psychiatric conditions (ADHD, anxiety, depression), you’re in the clear to prescribe stimulants or other controlled meds remotely under the federal waiver (www.cchpca.org).

Important: Texas requires you to check the state’s Prescription Monitoring Program (PMP) before prescribing any controlled substance—telehealth or in-person. This is non-negotiable.

New York: Recently Aligned State Law with Federal Flexibility

New York used to require in-person exams for controlled substances, but in mid-2025, the state finalized regulations that allow teleprescribing when consistent with federal law (www.nixonpeabody.com).

Practically: New York psychiatrists can now prescribe controlled meds via telehealth under the DEA’s temporary waiver without fear of violating state law. New York also requires e-prescribing for all controlled substances and mandates checking the state’s PMP registry before prescribing Schedule II–IV drugs.

One wrinkle: For Medicare patients, you may need an in-person visit every 6–12 months (this is a Medicare billing rule, not state law—but it’s worth planning for).

California: Telehealth Exams Count as ‘Good Faith Exams’

California requires a ‘good faith exam’ before prescribing, but telehealth exams qualify (natlawreview.com).

California defers to federal law on controlled substances, so during the DEA waiver period, you can prescribe stimulants and other psychiatric meds after a thorough video evaluation. You must enroll in CURES (California’s PMP) and check it at least every 4 months for ongoing controlled substance therapy.

California also has strong telehealth parity laws—private insurers must cover and reimburse telehealth at the same rate as in-person visits.

Pennsylvania and Illinois: Generally Permissive

Both states allow telemedicine prescribing as long as the standard of care is met and you’re licensed in the state where the patient is located. They follow federal controlled substance rules, so the DEA waiver applies.

Pennsylvania doesn’t have additional state-level restrictions on teleprescribing for psychiatry. Illinois has robust telehealth parity laws (insurers must pay the same for telehealth through at least 2027), which makes it financially viable to build a remote practice there.

What About Psychiatric Nurse Practitioners?

If you’re a PMHNP, your prescribing authority depends heavily on state scope-of-practice laws.

In full-practice states (like Washington, Oregon, Arizona, New York after 3,600 hours), you can prescribe independently just like a psychiatrist—including controlled substances via telehealth under the federal waiver.

In restricted states (like Texas and Florida), you’ll need a collaborative agreement with a supervising physician. In some cases, that physician must be a psychiatrist to delegate psychiatric prescribing (Florida requires this for PMHNPs prescribing psychotropic controlled substances) (www.flsenate.gov).

Texas is particularly restrictive: PMHNPs cannot prescribe Schedule II controlled substances (like Adderall) in most outpatient settings—only the supervising physician can (www.cchpca.org).

If you’re an NP practicing telehealth across state lines, you need to navigate each state’s collaboration requirements individually—it’s a compliance headache, but doable with the right systems in place.

Reimbursement: Telehealth Pays the Same as In-Person (Mostly)

One of the biggest wins from the pandemic: telehealth parity for mental health.

Medicare pays telepsychiatry visits at the same rate as in-person—about $95 for a 15-minute med check (CPT 99213) and $136 for a 25-minute follow-up (CPT 99214) as of 2026 (therathink.com). Initial evaluations (CPT 90792) pay around $173 (therathink.com).

Most private insurers follow suit—especially in states with parity laws like California, New York, Illinois, and Florida (where many insurers voluntarily pay equal rates even without a mandate).

For PMHNPs: Medicare reimburses at 85% of the physician rate when you bill under your own NPI (www.nursepractitioneronline.com). Some private payers do the same; others credential NPs at full parity depending on the state.

The takeaway: You can build a financially sustainable telepsychiatry practice focused on medication management, with reimbursement comparable to in-office work.

What You Need to Do to Stay Compliant

Here’s your checklist:

1. Get licensed in the state where your patient is located
   No shortcuts here. If you’re treating patients in multiple states, you’ll need multiple licenses. The Interstate Medical Licensure Compact (IMLC) can help if you’re in a member state (Texas, Pennsylvania, Illinois are members; New York, Florida, California are not).

2. Use a HIPAA-compliant video platform
   Zoom for Healthcare, Doxy.me, or your EHR’s built-in telehealth module. Document that you verified the patient’s identity and location.

3. Check your state’s Prescription Monitoring Program (PMP) before prescribing controlled substances
   Every state requires this now. Texas, New York, California, Florida—all mandate PMP checks. Build it into your workflow.

4. Document the telehealth encounter thoroughly
   Include the technology used, patient consent for telehealth, and an emergency plan if the patient disconnects during a crisis.

5. Stay updated on DEA rule changes
   The federal controlled substance prescribing landscape could shift by late 2024 or 2025. Subscribe to DEA updates or monitor legal summaries from groups like the American Psychiatric Association.

6. Coordinate with the patient’s primary care provider when appropriate
   If you’re prescribing lithium or other meds needing lab monitoring, make sure the patient has local lab access and that results get communicated.

The Business Case: Why Telepsychiatry Makes Sense in 2026

Here’s the reality: psychiatric prescribers are in massive demand, and traditional patient acquisition is expensive and slow.

DIY marketing—SEO, Google Ads, directory listings—can easily cost $200–500+ per patient when you factor in ad spend, agency fees, time wasted on leads that don’t convert, and months of investment before you see results.

Klarity Health uses a pay-per-appointment model: you only pay a standard listing fee when a pre-qualified patient books with you. No upfront marketing spend. No wasted ad budget. No months of waiting for SEO to kick in.

You get:

• Patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• Full control over your schedule

Instead of spending $3,000–5,000/month gambling on marketing with uncertain results, you pay only when you see patients. That’s guaranteed ROI, not hope-and-pray marketing.

For psychiatrists and PMHNPs looking to scale without the headache of building a practice from scratch, platforms like Klarity remove the patient acquisition risk entirely.

FAQs

Can psychiatrists prescribe Adderall or other stimulants via telehealth?
Yes, under the current DEA waiver (extended through December 31, 2025, and likely beyond). You can initiate stimulant prescriptions for ADHD after a thorough video evaluation in most states (texasnp.org).

Do I need an in-person visit before prescribing controlled substances?
Not currently, thanks to the federal telehealth waiver. However, this could change if the DEA finalizes new permanent rules. Stay updated on DEA policy announcements.

Can I prescribe across state lines?
Only if you’re licensed in the state where the patient is located at the time of the visit. You must follow that state’s telehealth and prescribing laws.

What about prescribing buprenorphine (Suboxone) for opioid use disorder via telehealth?
Yes, this is allowed under the DEA waiver. The federal X-waiver requirement was eliminated in 2023, so any DEA-registered practitioner can prescribe buprenorphine. You can initiate treatment via telehealth if clinically appropriate.

Do PMHNPs have the same prescribing authority as psychiatrists?
It depends on the state. In full-practice states (like New York, Washington, Oregon), experienced PMHNPs can prescribe independently. In restricted states (like Texas, Florida, Pennsylvania), they need physician collaboration or supervision—and some states limit what they can prescribe (e.g., Texas restricts Schedule II prescribing by NPs).

Will Medicare pay for telepsychiatry medication management?
Yes. Medicare reimburses telepsychiatry at the same rate as in-person visits. For mental health specifically, Medicare has extended telehealth flexibilities and may require an in-person visit once every 6–12 months for some patients, but this is still being clarified.

What if the DEA changes the rules?
The DEA has proposed implementing a special telemedicine registration or other requirements that could reinstate in-person exams for controlled substances. If that happens, you may need to conduct an initial in-person visit (or have a referral from another provider who did). Monitor DEA announcements and adjust your practice accordingly.

Do I need malpractice insurance for telehealth?
Yes. Make sure your malpractice policy explicitly covers telehealth services in the states where you’re licensed and practicing.

Bottom Line

Psychiatrists can prescribe medications—including controlled substances—via telehealth in 2026, thanks to federal waivers and state laws that support mental health access.

The key is staying compliant: get licensed in your patients’ states, check prescription monitoring programs, document thoroughly, and keep an eye on federal policy changes.

For providers looking to grow without the marketing headache, telehealth platforms that handle patient acquisition (like Klarity Health) offer a smarter path than spending thousands on ads and hoping for results.

The demand is there. The reimbursement is solid. The regulations—while complex—are workable.

Now’s the time to build a telepsychiatry practice that works for you.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship